UBA1 | ubiquitin-like modifier activating enzyme 1 | Xp11.23 | 0.364 | 0.585 | 0
|
MED14 | mediator complex subunit 14 | Xp11.4 | 0.316 | 0.493 | 0
|
USP9X | ubiquitin specific peptidase 9, X-linked | Xp11.4 | 0.31 | 0.494 | 0
|
PHF8 | PHD finger protein 8 | Xp11.22 | 0.306 | 0.515 | 0
|
GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | Xp11.22 | 0.302 | 0.513 | 0
|
INE1 | inactivation escape 1 (non-protein coding) | Xp11.4-p11.3 | 0.298 | 0.49 | 0
|
CTPS2 | CTP synthase 2 | Xp22 | 0.295 | 0.406 | 0
|
ZFX | zinc finger protein, X-linked | Xp22.1-p21.3 | 0.293 | 0.48 | 0
|
ZNF674 | zinc finger protein 674 | Xp11.3 | 0.293 | 0.474 | 0
|
DDX3X | DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked | Xp11.3-p11.23 | 0.293 | 0.505 | 0
|
UBXN4 | UBX domain protein 4 | 2q21.3-q22.1 | 0.292 | 0.349 | 1.56e-13
|
KDM6A | lysine (K)-specific demethylase 6A | Xp11.2 | 0.291 | 0.505 | 0
|
MED12 | mediator complex subunit 12 | Xq13 | 0.286 | 0.439 | 0
|
SMC1A | structural maintenance of chromosomes 1A | Xp11.22-p11.21 | 0.281 | 0.473 | 0
|
HCFC1 | host cell factor C1 | Xq28 | 0.275 | 0.349 | 1.5e-13
|
GRIPAP1 | GRIP1 associated protein 1 | Xp11.23 | 0.273 | 0.431 | 0
|
RAI1 | retinoic acid induced 1 | 17p11.2 | 0.272 | 0.367 | 5.98e-15
|
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Xp11.22 | 0.27 | 0.456 | 0
|
PIGA | phosphatidylinositol glycan anchor biosynthesis, class A | Xp22.1 | 0.264 | 0.369 | 4.01e-15
|
ZNF674-AS1 | ZNF674 antisense RNA 1 (head to head) | Xp11.23 | 0.26 | 0.448 | 0
|
CDK16 | cyclin-dependent kinase 16 | Xp11 | 0.256 | 0.462 | 0
|
KDM5D | lysine (K)-specific demethylase 5D | Yq11 | 0.255 | -0.187 | 1e-04
|
SAMD4B | sterile alpha motif domain containing 4B | 19q13.2 | 0.255 | 0.367 | 5.12e-15
|
DDX3Y | DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked | Yq11 | 0.251 | -0.193 | 6.12e-05
|
UBQLN2 | ubiquilin 2 | Xp11.21 | 0.248 | 0.374 | 1.33e-15
|
TNFSF12 | tumor necrosis factor (ligand) superfamily, member 12 | 17p13.1 | 0.247 | -0.355 | 5.2e-14
|
ELK1 | ELK1, member of ETS oncogene family | Xp11.23 | 0.247 | 0.457 | 0
|
EIF1AX | eukaryotic translation initiation factor 1A, X-linked | Xp22.13 | 0.246 | 0.401 | 0
|
PRICKLE3 | prickle homolog 3 | Xp11.23 | 0.246 | 0.453 | 0
|
MSL3 | male-specific lethal 3 homolog (Drosophila) | Xp22.3 | 0.245 | 0.414 | 0
|
USP9Y | ubiquitin specific peptidase 9, Y-linked | Yq11.2 | 0.244 | -0.184 | 0.00014
|
XIST | X inactive specific transcript (non-protein coding) | Xq13.2 | 0.24 | 0.266 | 2.71e-08
|
TBC1D25 | TBC1 domain family, member 25 | Xp11.23 | 0.24 | 0.263 | 3.98e-08
|
GLTSCR1 | glioma tumor suppressor candidate region gene 1 | 19q13.3 | 0.239 | 0.315 | 3.77e-11
|
AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | Xq22.3 | 0.237 | 0.359 | 2.38e-14
|
ZC3H7B | zinc finger CCCH-type containing 7B | 22q13.2 | 0.236 | 0.364 | 9e-15
|
CCDC120 | coiled-coil domain containing 120 | Xp11.23 | 0.235 | 0.453 | 0
|
UTY | ubiquitously transcribed tetratricopeptide repeat containing, Y-linked | Yq11.221 | 0.234 | -0.19 | 8.21e-05
|
ULK1 | unc-51 like autophagy activating kinase 1 | 12q24.3 | 0.231 | 0.316 | 2.86e-11
|
U2AF2 | U2 small nuclear RNA auxiliary factor 2 | 19q13.43 | 0.231 | 0.382 | 1.41e-16
|
GSPT2 | G1 to S phase transition 2 | Xp11.22 | 0.226 | 0.014 | 0.78
|
TSIX | TSIX transcript, XIST antisense RNA | Xq13.2 | 0.225 | 0.168 | 5e-04
|
IQSEC2 | IQ motif and Sec7 domain 2 | Xp11.23 | 0.224 | 0.338 | 9.78e-13
|
GTF2A1L | general transcription factor IIA, 1-like | 2p16.3 | 0.221 | -0.255 | 1.02e-07
|
LGALS12 | lectin, galactoside-binding, soluble, 12 | 11q13 | 0.221 | -0.318 | 2.33e-11
|
EIF1AY | eukaryotic translation initiation factor 1A, Y-linked | Yq11.223 | 0.219 | -0.297 | 4.35e-10
|
TFE3 | transcription factor binding to IGHM enhancer 3 | Xp11.22 | 0.219 | 0.277 | 6.49e-09
|
ATXN7L3 | ataxin 7-like 3 | 17q21 | 0.217 | 0.361 | 1.72e-14
|
SYAP1 | synapse associated protein 1 | Xp22.31 | 0.217 | 0.372 | 1.96e-15
|
PLCG1 | phospholipase C, gamma 1 | 20q12-q13.1 | 0.217 | 0.261 | 4.86e-08
|
ZNF746 | zinc finger protein 746 | 7q36.1 | 0.216 | 0.321 | 1.5e-11
|
EVC2 | Ellis van Creveld syndrome 2 | 4p16.2 | 0.215 | -0.178 | 0.000232
|
CDK7 | cyclin-dependent kinase 7 | 5q12.1 | 0.215 | 0.142 | 0.00336
|
EIF2S3 | eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa | Xp22.2-p22.1 | 0.214 | 0.344 | 3.73e-13
|
CCDC22 | coiled-coil domain containing 22 | Xp11.23 | 0.213 | 0.269 | 1.87e-08
|
NOL6 | nucleolar protein 6 (RNA-associated) | 9p12 | 0.211 | 0.251 | 1.71e-07
|
GNRHR2 | gonadotropin-releasing hormone (type 2) receptor 2, pseudogene | 1q12 | 0.207 | 0.049 | 0.309
|
DHCR24 | 24-dehydrocholesterol reductase | 1p32.3 | 0.207 | 0.08 | 0.0969
|
TNPO2 | transportin 2 | 19p13.13 | 0.206 | 0.334 | 1.79e-12
|
POLG | polymerase (DNA directed), gamma | 15q24 | 0.204 | 0.271 | 1.47e-08
|
CHST10 | carbohydrate sulfotransferase 10 | 2q11.2 | 0.203 | -0.112 | 0.0207
|
CA5BP1 | carbonic anhydrase VB pseudogene 1 | Xp22.2 | 0.203 | 0.4 | 0
|
PNPLA4 | patatin-like phospholipase domain containing 4 | Xp22.3 | 0.201 | 0.271 | 1.53e-08
|
MST1R | macrophage stimulating 1 receptor | 3p21 | 0.201 | 0.028 | 0.566
|
LOH12CR2 | loss of heterozygosity, 12, chromosomal region 2 (non-protein coding) | 12p13.2 | 0.2 | -0.223 | 3.61e-06
|
EXOC3-AS1 | EXOC3 antisense RNA 1 | 5p15.33 | 0.199 | 0.025 | 0.607
|
GYG1 | glycogenin 1 | 3q24-q25.1 | 0.197 | -0.205 | 1.97e-05
|
PRKX | protein kinase, X-linked | Xp22.3 | 0.196 | 0.361 | 1.78e-14
|
CA5B | carbonic anhydrase VB, mitochondrial | Xp22.1 | 0.195 | 0.218 | 5.76e-06
|
SLC24A5 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 5 | 15q21.1 | 0.191 | -0.179 | 0.00021
|
CLCN5 | chloride channel, voltage-sensitive 5 | Xp11.23-p11.22 | 0.189 | 0.261 | 4.8e-08
|
EEF2K | eukaryotic elongation factor 2 kinase | 16p12 | 0.183 | 0.102 | 0.0345
|
RSPO4 | R-spondin 4 | 20p13 | 0.179 | -0.005 | 0.92
|
PSKH1 | protein serine kinase H1 | 16q22.1 | 0.167 | 0.095 | 0.0487
|